Jiangsu Apon Medical Technology Co Ltd Class A
Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. The company's principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers. Jiang… Read more
Jiangsu Apon Medical Technology Co Ltd Class A (300753) - Total Liabilities
Latest total liabilities as of September 2025: CN¥153.56 Million CNY
Based on the latest financial reports, Jiangsu Apon Medical Technology Co Ltd Class A (300753) has total liabilities worth CN¥153.56 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jiangsu Apon Medical Technology Co Ltd Class A - Total Liabilities Trend (2014–2024)
This chart illustrates how Jiangsu Apon Medical Technology Co Ltd Class A's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Jiangsu Apon Medical Technology Co Ltd Class A Competitors by Total Liabilities
The table below lists competitors of Jiangsu Apon Medical Technology Co Ltd Class A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Xiamen Guang Pu Electronics Co Ltd
SHE:300632
|
China | CN¥859.36 Million |
|
SF Urban Properties AG
SW:SFPN
|
Switzerland | CHF508.15 Million |
|
Guangbo Group Stock Co Ltd
SHE:002103
|
China | CN¥995.15 Million |
|
Pubang Landscape Architecture Co Ltd
SHE:002663
|
China | CN¥2.11 Billion |
|
Clearfield Inc
NASDAQ:CLFD
|
USA | $18.40 Million |
|
Momentum Group AB Series B
LSE:0RTK
|
UK | Skr5.95 Billion |
|
BOTH Engineering Technology Co. Ltd. A
SHG:601133
|
China | CN¥2.78 Billion |
|
Coca-Cola Embonor S.A
SN:EMBONOR-B
|
Chile | CL$622.25 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Jiangsu Apon Medical Technology Co Ltd Class A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.18 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangsu Apon Medical Technology Co Ltd Class A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
The table below shows the annual total liabilities of Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥155.62 Million | -4.16% |
| 2023-12-31 | CN¥162.38 Million | -11.68% |
| 2022-12-31 | CN¥183.85 Million | +55.10% |
| 2021-12-31 | CN¥118.54 Million | +35.63% |
| 2020-12-31 | CN¥87.40 Million | +5.60% |
| 2019-12-31 | CN¥82.76 Million | +11.00% |
| 2018-12-31 | CN¥74.56 Million | +38.41% |
| 2017-12-31 | CN¥53.87 Million | -17.02% |
| 2016-12-31 | CN¥64.92 Million | +86.12% |
| 2015-12-31 | CN¥34.88 Million | +1.31% |
| 2014-12-31 | CN¥34.43 Million | -- |